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Background: Cerebellar abiotrophy (CA) is a rare but significant disease in Arabian horses caused by progressive
death of the Purkinje cells resulting in cerebellar ataxia characterized by a typical head tremor, jerky head
movements and lack of menace response. The specific role of magnetic resonance imaging (MRI) to support clinical
diagnosis has been discussed. However, as yet MR imaging has only been described in one equine CA case. The
role of MR morphometry in this regard is currently unknown. Due to the hereditary nature of the disease, genetic
testing can support the diagnosis of CA.
Therefore, the objective of this study was to perform MR morphometric analysis and genetic testing in four
CA-affected Arabian horses and one German Riding Pony with purebred Arabian bloodlines in the third generation.
Results: CA was diagnosed pathohistologically in the five affected horses (2 months - 3 years) supported by clinical
signs, necropsy, and genetic testing which confirmed the TOE1:g.2171G>A SNP genotype A/A in all CA-affected horses.
On MR images morphometric analysis of the relative cerebellar size and relative cerebellar cerebrospinal fluid (CSF)
space were compared to control images of 15 unaffected horses. It was demonstrated that in MR morphometric
analyses, CA affected horses displayed a relatively smaller cerebellum compared to the entire brain mass than control
animals (P = 0.0088). The relative cerebellar CSF space was larger in affected horses (P = 0.0017). Using a cut off value of
11.0% for relative cerebellar CSF space, the parameter differentiated between CA-affected horses and controls with a
sensitivity of 100% and a specificity of 93.3%.
Conclusions: In conclusion, morphometric MRI and genetic analysis could be helpful to support the diagnosis of
CA in vivo.
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Cerebellar abiotrophy (CA) is a neurological disease char-
acterized by intrinsic spontaneous degeneration of prema-
ture neuronal cells. An inherited polymorphism is assumed
to be responsible for the changes in the metabolic activity
of the Purkinje neurons [1].
CA is found in Arabians and partbred Arabian horses
but it has also been reported in the Gotland pony and the
Oldenburg Warmblood horse [2,3]. CA is seen in several* Correspondence: jessika.cavalleri@tiho-hannover.de
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reproduction in any medium, provided the orspecies including dogs, sheep and cattle, but it is likely that
in these species, CA does not have the same aetiology as
in the horse [1,4,5]. Most CA-affected horses appear to be
normal at birth. Progressive degeneration of Purkinje cells
causes clinical signs – in most cases between the time of
birth and six months of age, however a manifestation later
in life is also possible [6-10]. Affected foals often show
head tremors (intention tremor), reduced or absent men-
ace response and cerebellar ataxia. An exaggerated action
of the forelegs, hyperactivity and the tendency to startle
and fall are often described [8-10]. Despite distinctive clin-
ical signs, ante mortem diagnosis remains suggestive and
definite diagnosis needs histopathological examinationl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ation of the granular cells, disorganizations of the molecu-
lar and granular layers of the cerebellar cortex and
shrunken Purkinje cells [9,10,12].
For intra vitam diagnosis of CA the use of MRI is
not widely used or described in horses [11]. In dogs, on
the other hand, several studies showed the usefulness
of this diagnostic imaging technique for the diagnosis
of cerebellar degenerative diseases [13-20].
Lately, efforts have been made to develop a genetic test
for diagnosis of CA [8]. Since in horses a single autosomal
recessive locus is assumed to be responsible for the
disease, chromosomal regions have been scanned for
mutations involved in CA development [8]. Recently, link-
age analyses refined the map location for CA on horse
chromosome (ECA) 2 at 13.05-13.19 Mb (megabases) to a
conserved haplotype spanning 142 kb [8]. Complete se-
quencing of four annotated genes TESK2, HPDL, TOE1
and MUTYH occupying approximately 49.7 kb of the 142
kb region revealed a single nucleotide polymorphism
(TOE1:g.2171G>A SNP) within TOE1 associated with CA
in Arabian horses [8]. The aims of the current study are
the assessment of subjective evaluation of brain MRI, ob-
jective MR morphometry and genetic testing regarding
their value in diagnosing CA intra vitam in horses with
histologically proven disease.
We hypothesize that MR morphometry and genetic test-
ing can support a diagnosis of CA in Arabian horses.Methods
Five horses, two colts and three fillies ranging in weight
from 104 to 294 kg, and aged from 2 to 36 months (median
age 19 months), were examined. History of clinical
signs and the patients’ pedigrees were provided by breeders
or owners, respectively. Horses CA 1 to CA4 were pure-
bred Arabian horses whereas horse CA 5 was a partbred
Arabian pony.
All five horses were examined clinically and neuro-
logically. The clinical-neurological examination in-
cluded the monitoring of behavior, posture, postural
reactions and gait. Cranial nerve examination, spinal
reflexes and sensibility were tested.
For further diagnostic tests blood samples and cerebro-
spinal fluid (CSF) samples were taken under anesthesia
immediately before the foals were euthanized. Thereby,
10 ml CSF were obtained under sterile conditions
by an atlanto-occipital spinal tap. Hematologic and
blood biochemical analysis were performed evaluating
blood urea nitrogen, creatinine, lactate, glucose, bilirubin,
triglycerides, sodium, calcium, potassium, chloride, aspar-
tate aminotransferase, lactate dehydrogenase, gamma-
glutamyltransferase, glutamate dehydrogenase, creatine
kinase and alkaline phosphatase.Neuroimaging
Magnetic resonance examinations were performed under
general anesthesia. For general anesthesia, horses were
sedated to individual needs with xylazine (Xylazin 2%,
cp-pharma, Burgdorf, Germany; 0.5-1.1 mg/kg i.v.).
General anesthesia was induced with ketamine (Narketan
100 mg/mL, Vetoquinol, Ravensburg, Germany; 2.5 mg/kg
i.v.) and midazolam (Midazolam 5 mg/mL, Braun,
Tuttlingen, Germany; 0.06 mg/kg i.v.), and maintained
with inhalation of isoflurane (Isofluran, cp-pharma,
Burgdorf, Germany) in oxygen.
MRI was performed using a 3 Tesla scanner (Achieva
TX, Philips Medical System, Philips GmbH, Hamburg,
Germany). The heads were scanned in dorsal recum-
bency, four connected flexible coils were used to obtain
the images. The scanning protocol included T2 Turbo
spin echo sequences (T2w TSE; TR: 3000; TE: 15) in
dorsal, sagittal, and transverse planes, a fluid attenu-
ation inversion recovery (FLAIR) sequence in sagittal
and transverse planes (TR: 10000; TE: 36, IR: 2600), and
3D T1 weighted pre- and post contrast sequences with
a slice thickness of 4 mm. The 3D T1 sequence was
reconstructed in a slice thickness of 0.9 mm. Gadoterate
meglumine (Gd-DOTA; Dotarem®, Guerbet, Sulzbach,
Germany) was administered at an intravenous dose of 0.02
mmol/kg to serve as a contrast agent. In one case (CA1),
additionally, a T2 FFE HEMO (T2* fast field echo) transver-
sal sequence (TR: 675 TE: 13) and diffusion sequences
were performed.
For evaluation of the cerebellar parenchyma, se-
quences were assessed subjectively by two authors indi-
vidually, paying special attention to the visibility of the
cerebellar vermis, the amount of CSF around the cere-
bellum, in particular in the region of the fourth ven-
tricle and between the folia. For morphometric analysis
a midsagittal T2-weighted image (Matrix 512 × 512,
voxel size of 0.3 × 0.4 × 4 mm) was chosen for each
horse. The outline of the whole brain, the cerebellum
and the CSF space surrounding the cerebellum was
marked manually by two experienced examiners (dual-
control principle) using a software suitable for analyz-
ing veterinary diagnostic images (current release of
Easyimage, VetZ, Isernhagen, Germany) (Figure 1A-C).
Outline measurements were repeated twice and mean
values were used for further analysis. As described else-
where [14], relative cerebellar size and relative CSF space
were calculated. Briefly, to specify the relative cerebellar
size the area of the cerebellum was divided by the area of
the whole brain and multiplied by 100. For assessment of
the relative cerebellar CSF space, the cross sectional area
of the cerebellum was subtracted from the cross sectional
area of the cerebellum plus its surrounding CSF space and
divided by the cross sectional area of the cerebellum plus
surrounding CSF multiplied by 100.
Figure 1 Outline of MRI morphometric calculations on midsagittal images midsagittal T2-weighted MRI of horse CA5 (A). The
cerebellum, its surrounding CSF space and the whole brain were outlined manually and the ratio of the area of the cerebellum and the area
of the cerebellum plus its surrounding CSF space (checkered pattern) was calculated (B). To obtain the relative cerebellar size, the area of
the cerebellum was put into a ratio with the area of the whole brain (irregular pattern) (C).
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surements, midsagittal MR images of 15 neurologic-
ally unremarkable, adult horses’ brains were used.
Identical settings as mentioned above for the MRexamination of affected horses were used. Analysis
was performed in one adult Arabian horse and 14
Warmbloods with a median age of 4 years (6 months
to 10 years).
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Genomic DNA of the affected horses (n=5) and
their parents (n=10) was isolated from EDTA
(ethylenediaminetetraacetic acid) blood samples (using
500 μL EDTA blood drawn from one jugular vein) by
saline precipitation [21] and DNA concentration
was adjusted to 10 ng/μL. Microsatellites were chosen
from a marker set covering the whole equine genome
(EquCab2.01) at a mean distance of 112 kb [22]. Five out
of twenty microsatellites in the region of 11.89-14.06 Mb
were selected according to their high polymorphism infor-
mation content (PIC) and heterozygosity (HET). Primer
pairs were designed for the microsatellites and the TOE1:
g.2171G>A SNP using Primer32 (Additional file 1). For
PCR amplification of the microsatellites and the TOE1:
g.2171G>A SNP, reactions were assembled in 10 μL/
30 μL total volume containing 2 μL sample DNA, 1.2 μL/
3.1 μL incubation mix with MgCl2 (buffer; Taq Core Kit
10 (1000 U), MP Biomedicals, LLC, Germany), 0.15 μL/
0.60 μL dNTP mix (Taq Core Kit 10 (1000 U), MP Biomed-
icals) at 10 mM, 0.1 μL/ 0.12 μL Taq Polymerase (5 U/ μL;
Taq Core Kit 10 (1000 U), MP Biomedicals), 2.4 μL/
6.24 μL 5× enhancer solution P (Enhancer solution, Peqlab
Biotechnologie GmbH, Erlangen, Germany) and 0.03 -
0.09 μL (100 pmol/μL) 5’-IRD700 or IRD800 fluorescence
labeled/ unmodified primers. Thermocycling on a PTC
200™ thermocycler (PTC 200™ thermocycler, MJ Research,
Inc., Waltham, USA) was performed for both reactions
using the following settings: 4 min at 94°C, followed by 36
cycles of 94°C for 30 s, 1 min at 60 °C, 30 s at 72°C and fi-
nally 10 min at 4°C. PCR products of the microsatellites
were size-fractioned by gel electrophoresis on 6% poly-
acrylamide denaturing gels (RotiphoreseGel 40, Carl Roth)
using an automated capillary sequencer (LI-COR 4200/S-
2, LI-COR 4300, LI-COR Biotechnology GmbH, Bad
Homburg, Germany). The data were analyzed by visual
examination. Genotyping the TOE1:g.2171G>A SNP was
performed by sequence analysis using the automated
sequencer Genetic Analyzer 3500 (Genetic Analyzer
3500, Applied Biosystems by Life Technologies GmbH,
Darmstadt, Germany). Haplotypes for the affected horses
and their parents were reconstructed using MERLIN (ver-
sion 1.1.2) [23].
Pathology
At necropsy, the total body weight, brain weight and the
weight of the isolated cerebellum were determined.
Brain and spinal cord were fixed in 10% buffered forma-
lin (pH 7.4). Randomly selected samples of cerebral cor-
tex, corpus striatum, hippocampus, cerebellar cortex and
brain stem as well as of cervical, thoracal and lumbal
spinal cord were embedded in paraffin. Three μm thick
sections were stained with hematoxylin and eosin (HE).
Brain and spinal cord of two Arabian horses, 24 and 48months of age and without any evidence of neurological
disease, either clinical or pathological, were similarly
prepared and served as controls.
Ethical approval
All animal work has been conducted according to the
national and international guidelines for animal welfare.
The sampling was approved by the Lower Saxony
state veterinary office Niedersächsisches Landesamt
für Verbraucherschutz und Lebensmittelsicherheit,
Oldenburg, Germany (registration number 33.9-42502-
05-11A160).
Statistical analysis
To evaluate the MR morphometric assessment of the rela-
tive cerebellar size and CSF space descriptive statistics of
the 15 control images included median and range of values.
Wilcoxon rank test was used to compare the measure-
ments between CA affected horses and neurologically
healthy horses. Significance was set at P < 0.05. The sensi-
tivity and specificity of the tests were calculated using
standard statistical software (graphpad prism5). The cutoff
value for sensitivity and specificity calculations was set
using the optimal likelihood ratio after receiver operator
characteristic analysis.
Results
At clinical examination, the vital parameters of the exam-
ined horses were within their normal range. History and
clinical neurological examination of the horses were com-
patible with cerebellar disease in all five horses (Table 1).
They were overexcited and hyperreacted to unspecified
stimuli. Four horses displayed a head tremor that became
more pronounced due to mental stress caused by the
examination, feed intake and introduction to a new envir-
onment. Based on the neurologic examination, lesions
were localized intracranially and due to reduced menace
response with intact eyesight, head tremors and hypermet-
ric ataxia, the cerebellum was identified as the site of the
lesion in all horses. Complete blood cell count, blood bio-
chemistry results and CSF analysis were within normal
limits. The only deviations from normal values were
hyperglycemia in all five horses, mild hyperlactatemia (1.7
mmol/L; reference 0–0.7 mmol/L) in horse CA1, and mild
increase in gamma-glutamyltransferase (31 U/L; reference
0–20 U/L) in horse CA2.
Molecular genetic analysis
Genotyping the TOE1:g.2171G>A SNP revealed that all
clinically CA-affected horses had the genotype A/A while
their parents showed the genotype G/A. The information
about the gene flow in the pedigree on the basis of the
microsatellite genotypes in the region around the TOE1:
g.2171G>A SNP was used to reconstruct haplotypes for
Table 1 Patient data of 5 horses with histologically confirmed CA and comparative median values of MR morphometry
of 15 control horses (controls)
CA1 CA2 CA3 CA4 CA5 Controls
Signalment
Gender Filly Filly Colt Colt Filly
Weight (kg) 212 232 244 294 104
Clinical details
Onset (months) 0 18 6 12 0
Age at examination (months) 19 42 19 13 2
Ataxia + - + + +
Head tremor + + + - +
Abnormal menace response + - + + +
Clinical neuroanatomic location of lesion Cerebellum Cerebellum Cerebellum Cerebellum Cerebellum
MR morphometry
Relative cerebellar size (%) 15.4 19.6 17.2 19.3 16.3 20.3 (18.8-22.7)
Relative cerebellar CSF space (%) 17.4 16.3 11.8 13.5 20.8 9.4 (6.2-13.3)
Pathology
Brain weight (g) 400 500 472 470 390
Weight (g) (isolated cerebellum) 27 47 37 48 25
Cerebellum: whole brain ratio (%) 6.75 9.4 7.8 10.2 6.41
Purkinje cell degeneration + + + + +
Genetic testing
CA-associated TOE1 genotype + + + + +
Conserved haplotype + + + + +
CA - cerebellar abiotrophy.
MRI - magnetic resonance imaging.
CSF - cerebrospinal fluid.
Values in parenthesis show the range of calculated ratios for the controls.
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homozygous haplotype 158-209-141-A-194-249 spanning
the region of 11.89-14.06 Mb, while their parents were
heterozygous for the CA-associated haplotype. Pedigree
analysis revealed that three horses had a common ancestor
while CA4 and CA5 could not be linked to that family
within seven generations back (Additional file 2).
Neuroimaging
The MR images were evaluated in sagittal, dorsal, and
transverse planes. In horses CA1, CA2, and CA5 the
amount of CSF in the 4th ventricle and around the cerebel-
lum, especially between the folia, subjectively seemed to be
increased compared to healthy horses. In horse CA3 and
CA4 this finding was subjectively not evident. Morphomet-
ric analysis on midsagittal T2 weighted images estimating
the relative cerebellar size and relative CSF space revealed a
significantly lower relative cerebellar size of CA-affected
horses compared to healthy Warmblood horses (Wilcoxon
rank test, P ≤ 0.0088, Table 1, Figure 2). The median rela-
tive cerebellar size of control horses (n = 15) was 20.3%
(range: 18.8 – 22.7%), whereas CA-affected horses had amedian relative cerebellar size of 17.6% (15.4 – 19.6%).
Using a cut off value of 18.9%, MR morphometric assess-
ment of relative cerebellar size was capable of identifying
CA with a sensitivity of 60% and a specificity of 93.3%.
The median relative cerebellar CSF space of control
horses was 9.4% (range: 6.2 – 13.3%). In the five CA
affected horses, median cerebellar CSF space measured
16.3% (11.8 – 20.8%). This difference was significant
(Wilcoxon rank test, P = 0.0017). Using a cut off value
of 11.0%, the sensitivity of the test in identifying CA
affected horses was calculated as 100% and its specificity
as 93.3%.
Pathology
On macroscopic examination the cerebellar folia appeared
thinner than normal in all horses. The cerebellum to
whole brain weight (cerebellum/ whole brain %) was
below the lower reference value of 8% [24] in three horses
(CA1, CA3, CA5) (Table 1). This corresponds well with
the relative cerebellar size calculated from MRI analysis,
which in these horses also showed lower values than con-
trols. In contrast, the relative cerebellar CSF space did
Figure 2 Distribution of MR morphometric results in study population. Filled symbols represent affected horses, unfilled symbols symbolize
values obtained from 15 control MRI. The age of the horses is set against the relative cerebellar CSF space, or the relative cerebellar size.
Figure 3 Cerebellar folium with hypocellular granular layer and
ectopic neurons (block arrow). The Purkinje cell layer exhibits a
reduced number of cells and proliferation of Bergman glia
(line arrows) (hematoxilin and eosin staining, scale bars 200 μm).
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Pathohistologically, the cerebellum showed a moderate to
marked hypocellularity of the granular layer in all cases.
Furthermore, a loss of Purkinje cells as well as ectopic
Purkinje cells within the granular layer, were observed.
Moreover, a proliferation of Bergmann glia next to the
Purkinje cell layer was seen (Figure 3). The degree of these
changes varied within different segments of the cerebel-
lum. The sum of these changes led to the diagnosis of CA
in all five cases. In addition to the above findings, CA3
showed some axonal spheroids in the cervical and lumbal
spinal cord as well as a focal gliosis in the commisura
grisea of the lumbal spinal cord. Several chromatolytic
neurons were found in several basal ganglia, in the nucleus
intercalatus, motoric nervi hypoglossi, cuneatus and
vestibularis caudalis of the brainstem of CA2. In contrast
to the affected horses, controls showed organized molecu-
lar and granular layers and intact Purkinje cells in the
cerebellum. The cerebrum was unremarkable in all horses.
Our findings in histopathological examinations confirmed
the diagnosis of CA and was subsequently used as the gold
standard in our evaluation of MRI and genetic testing as
alternative diagnostic tools.
Discussion
In the current study, we were able to demonstrate that MR
brain morphometry supported the etiological and genetic
diagnosis of cerebellar abiotrophy in four Arabian horses
and one partbred Arabian pony foal. Pathologic and histo-
pathologic results confirmed the diagnosis. In all cases the
horses showed clinical signs of CA and the TOE1 genotype
A/A in accordance with previous reports [8]. Pathologicand histopathologic examinations revealing Purkinje cell
loss and a marked hypocellularity of the granular layer veri-
fied the results. Based on those findings MR brain morph-
ometry was able to identify CA using cut off values of
18.9% for the relative cerebellar size and 11.0% for the rela-
tive cerebellar CSF space while subjective MRI evaluation
only detected rather mild changes. However, these values
should not be overemphasized since there was an overlap-
ping between normal and affected horses and the cut off
value of 18.9% for the relative cerebellar size had a rather
low sensitivity of 60%.
In our study, the amount of CSF around the cerebel-
lum and between the cerebellar folia appeared to be
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This corresponds well to the MRI findings reported in
CA-affected dogs [13,14,19,20]. However, an increased
visibility of the arbor vitae which was described in a
CA-affected Arabian foal [11], was not detected in the
cases studied here and in two of the affected horses sub-
jective MRI evaluation was unremarkable.
CA is a neurologic disease affecting growing young
horses with clinical signs generally beginning during the
first year of life [10,11,24-30]. Although history, clinical
signs and supportive laboratory data are used to make a
presumptive diagnosis [31], definite diagnosis is only pos-
sible by histopathology [8,11,12]. Therefore, histopatho-
logic evaluation was considered the gold standard in the
diagnosis of CA in this study.
MRI is a non-invasive diagnostic imaging modality
providing high anatomical detail and soft tissue contrast
in the central nervous system. In addition, MRI of the
equine head has proved to be feasible and useful in the
diagnosis of neurologic diseases [32]. It has been used
frequently to support the diagnosis of cerebellar degen-
erative diseases in dogs [13-17,19,20]. However, in the
horse, only limited data are available describing MRI
findings in Arabian foals suffering from CA [11].
Computer-assisted magnetic resonance imaging brain
morphometry was performed to assess the relative cere-
bellar size and the relative CSF space surrounding the
cerebellum in a midsagittal plane. Similar to the results
in dogs obtained by Henke et al. [14], the morphometric
analysis of both relative cerebellar size and relative cere-
bellar CSF space differentiated between CA-affected
horses and neurologically healthy horses. However, due
to the small sample size the data have to be interpreted
with care. Based on sensitivity and specificity calcula-
tions, the measurement of relative cerebellar CSF space
was superior to the measurement of relative cerebellar
size in detecting CA-affected horses.
The MR morphometric analysis results are well sup-
ported by the measurement of the relative cerebellar
weight during postmortem exam. The relative cerebellar
weight (C:WB ratio) was shown to be below 8% in CA-
affected horses [24]. This corresponds well to the foals
in our study, showing a C:WB ratio of less than 8% in
horses CA1, CA3, and CA5, in which the morphometric
analysis of relative cerebellar size also showed markedly
smaller values than the control horses and horses CA2
and CA4.
In this study the MR morphometric calculation of
cerebellar CSF space had a stronger significance than
the relative size of the cerebellum leading to a more
precise detection of affected horses. The relatively low
sensitivity of 60% for the relative cerebellar size could
be in part explained by the small sample size of dis-
eased horses in the current study. In AmericanStaffordshire Terriers, relative cerebellar size was able
to identify cerebellar degeneration with a sensitivity of
93% [14]. One difference in the study design was a
greater sample size (14 diseased vs. 17 control dogs).
The two horses with a relative cerebellar size within
the control range were also the two horses that showed
less clinical signs, milder histopathological changes,
and a cerebellum to whole brain weight ratio within
the normal range. Thus, in this study, measurement of
relative cerebellar size was only able to identify CA-
diseased horses correctly in advanced disease. It is
open to speculation whether sensitivity might increase
with a higher sample size.
Although these results are promising and give an opti-
mistic view of the diagnostic capability of MRI for CA, it is
important to note that the control MR images were
obtained mainly from Warmblood horses with a median
age of 4 years and not from juvenile Arabian horses. It is
unclear whether these differences in age and breed have a
significant influence on the obtained results. However, a
study in dogs compared the percentage of the brain occu-
pied by the cerebellum in different breeds with different
skull types and found no significant differences between the
breeds [19]. It seems therefore likely that the only slightly
different skull shape of different horse breeds will probably
not lead to measurable differences in the relative cerebellar
size. Currently, there are no comparative studies on the
MRI appearance and relative cerebellar size in horses of dif-
ferent breeds or ages.
Thus, the results suggest that MRI can not only help
to confirm the diagnosis of a suspected CA case because
of subjective increases in amount of CSF within and
around the cerebellum, but using computer-assisted
morphometric analysis in particular can provide object-
ive criteria in support of the diagnosis.
The genetic analysis showed a highly conserved haplo-
type at 11.89-14.06 Mb in the region of the TOE1 gene and
the TOE1 flanking region in all affected horses including
CA4 and CA5 which were not related to the other horses.
The TOE1:g.2171G>A SNP genotype A/A was associated
with CA affliction. We assume that the haplotype sur-
rounding the TOE1 gene is highly conserved. This finding
may suggest the existence of common founders in CA-
affected Arabians many generations ago. This SNP located
in exon 4 of TOE1 results in a non-synonymous substitu-
tion of histidine for arginine. It is supposed that this substi-
tution affects TOE1 as a transcriptional regulator and
mediator of the inhibitory growth effect of Early Growth
Response 1 (EGR1). The role of the SNP influencing the ex-
pression of the mutY Homolog (E. coli) (MUTYH) gene
has also been discussed [8]. It can be assumed that due to
the high conservation of the haplotype among the affected
horses the analyzed region contains a causal mutation for
CA [8,33].
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In conclusion, to establish a valid ante mortem diagnosis
for CA in horses, it is desirable to provide feasible and ef-
fective diagnostic tools. Due to the genetic pathogenesis of
the disease, a gene test identifying the animals at risk for
developing the disease is one such tool especially suitable
for early diagnosis. MR imaging together with MR brain
morphometry, on the other hand, is a valid method to help
to confirm the diagnosis in clinically advanced stages. On
basis of clinical and genetic results MR imaging is a sensi-
tive intra vitam tool to support the diagnosis of CA in
manifest cases. Nonetheless, the evaluation of a larger num-
ber of horses in different states of manifestation and MR
morphometric analysis of morphologically healthy brains of
Arabian horses should further substantiate the results
obtained in this study.
Additional files
Additional file 1: Characteristics of the microsatellite and SNP markers
used in this study.
Additional file 2: Pedigree of three CA-affected horses (CA1-3) and
their haplotypes spanning the region at 11.89-14.06 Mb. CA4 and
CA5 showed the same haplotype but could not be linked to the
pedigree. Squares: males; circles: females; solid symbols: clinically affected
horses; half-filled symbols: obligate genetic carriers; unfilled symbols:
unknown phenotype; black boxes: CA-associated haplotype; boxes of
different patterns: haplotypes not associated with CA. All three cases
have a common ancestor (A). Haplotypes: fragment sizes of the
microsatellites and the TOE1:g.2171G>A SNP alleles are given according
to their location on ECA2. All affected horses have a homozygous
haplotype 158-209-141-A-194-249.
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